Untreated Mild Hyperglycemia During Pregnancy and Anthropometric Measures of Obesity in Offspring at Age 5-7 Years

Parag K Thaware1, Sonia McKenna2, Christopher C Patterson3

  • 1Royal Victoria Hospital, Belfast, U.K. Queen's University Belfast, Belfast, U.K.

Diabetes Care
|June 21, 2015
PubMed

Insights

Maternal hyperglycemia during pregnancy, even without diabetes, does not increase offspring obesity risk. This finding holds true after accounting for maternal body mass index (BMI) at the oral glucose tolerance test (OGTT).

Area of Science:

  • Reproductive Endocrinology
  • Pediatric Endocrinology
  • Metabolic Disorders

Background:

  • Previous studies suggest a link between maternal hyperglycemia during pregnancy and offspring obesity.
  • Conflicting results exist regarding the strength and nature of this association.
  • The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study provides a robust dataset to investigate this relationship.

Purpose of the Study:

  • To examine the association between maternal hyperglycemia during pregnancy and offspring anthropometry.
  • To determine if maternal glucose levels during gestation predict childhood obesity (ages 5-7 years).
  • To clarify the role of maternal pre-pregnancy BMI in this association.

Main Methods:

  • Mothers from the HAPO Study in Belfast underwent an oral glucose tolerance test (OGTT) at ~28 weeks gestation.
  • Offspring anthropometry (weight, height, skinfold thickness) was measured at 5-7 years of age.
  • Multiple regression analysis was used, adjusting for maternal BMI at OGTT and offspring birth weight z-score.

Main Results:

  • Maternal fasting plasma glucose (FPG), 1-hour plasma glucose (1h PG), and 2-hour plasma glucose (2h PG) were not associated with offspring BMI z-score or skinfold sum.
  • This lack of association persisted when defining offspring overweight, obesity, or extreme obesity using BMI z-scores.
  • The initially observed relationship between maternal FPG and offspring adiposity was fully explained by maternal BMI at the time of the OGTT.

Conclusions:

  • Higher maternal FPG concentration during pregnancy, below the threshold for diabetes, is not an independent risk factor for offspring obesity.
  • Maternal BMI at the time of the OGTT is a significant confounder in the relationship between maternal glycemia and offspring adiposity.
  • These findings suggest that interventions targeting maternal weight may be more effective in preventing childhood obesity related to pregnancy glucose metabolism.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.2K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K